India Revokes Roche’s Pegasys Patent On Grounds Of Obviousness
This article was originally published in PharmAsia News
Executive Summary
Roche has faced persistent debacles in defending its drug patents in India. In the latest setback, a patent appellate board has revoked the first-ever product patent granted in India.